Habib Peter M, Serena Thomas, Derosa Amy
Department of Surgery, Beaumont Hospital-Farmington Hills, Farmington Hills, USA.
Cureus. 2022 Mar 31;14(3):e23680. doi: 10.7759/cureus.23680. eCollection 2022 Mar.
Since the advent of breast implants, there has been unprecedented controversy and FDA bands regarding their safety. There has been a demonstrated link with certain types of lymphoma, autoimmune disorders, and systemic illness associated with breast implants. A significant population of women currently pursue bilateral breast implant removal in hopes to alleviate a constellation of symptoms anecdotally known as "breast implant illness". This is not yet an accepted clinical entity due to the lack of sound literature on the subject. Common presenting symptoms include fatigue, anxiety, chronic pain, endocrine, autonomic, and peripheral nervous system dysfunction. Currently, there is no standard of care or guideline for treating women experiencing such symptoms. The current literature regarding breast implant illness has been widely observational and descriptive. With over four million women across the globe with augmented breasts, the potential impact of this research is great. This paper presents three patients believed to be suffering from breast implant illness, who after en-bloc resection, experienced resolution of their symptoms.
自隆胸植入物问世以来，关于其安全性出现了前所未有的争议和美国食品药品监督管理局（FDA）的禁令。已证实隆胸植入物与某些类型的淋巴瘤、自身免疫性疾病以及全身性疾病存在关联。目前有相当一部分女性寻求双侧隆胸植入物取出，以期缓解一系列被坊间称为“隆胸植入物疾病”的症状。由于缺乏关于该主题的可靠文献，这一病症尚未成为被认可的临床实体。常见的症状包括疲劳、焦虑、慢性疼痛、内分泌、自主神经和周围神经系统功能障碍。目前，对于出现此类症状的女性，尚无治疗的标准护理方案或指南。当前关于隆胸植入物疾病的文献大多是观察性和描述性的。全球有超过四百万女性隆乳，这项研究的潜在影响巨大。本文介绍了三名被认为患有隆胸植入物疾病的患者，她们在进行整块切除术后症状得到缓解。
